217 related articles for article (PubMed ID: 31778740)
1. Enhanced cellular uptake and nuclear accumulation of drug-peptide nanomedicines prepared by enzyme-instructed self-assembly.
Liang C; Yan X; Zhang R; Xu T; Zheng D; Tan Z; Chen Y; Gao Z; Wang L; Li X; Yang Z
J Control Release; 2020 Jan; 317():109-117. PubMed ID: 31778740
[TBL] [Abstract][Full Text] [Related]
2. Nuclear delivery of dual anti-cancer drugs by molecular self-assembly.
Wu J; Ding W; Han G; You W; Gao W; Shen H; Tang J; Tang Q; Wang X
Biomater Sci; 2021 Jan; 9(1):116-123. PubMed ID: 33325919
[TBL] [Abstract][Full Text] [Related]
3. Nuclear delivery of dual anticancer drug-based nanomedicine constructed by cisplatinum-induced peptide self-assembly.
Xu T; Liang C; Zheng D; Yan X; Chen Y; Chen Y; Li X; Shi Y; Wang L; Yang Z
Nanoscale; 2020 Jul; 12(28):15275-15282. PubMed ID: 32644059
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-assisted peptide folding, assembly and anti-cancer properties.
Liang C; Zheng D; Shi F; Xu T; Yang C; Liu J; Wang L; Yang Z
Nanoscale; 2017 Aug; 9(33):11987-11993. PubMed ID: 28792044
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-Instructed Supramolecular Self-Assembly with Anticancer Activity.
Yao Q; Huang Z; Liu D; Chen J; Gao Y
Adv Mater; 2019 Nov; 31(45):e1804814. PubMed ID: 30444545
[TBL] [Abstract][Full Text] [Related]
6. An NRP1/MDM2-Targeted D-Peptide Supramolecular Nanomedicine for High-Efficacy and Low-Toxic Liver Cancer Therapy.
Zhou Y; Chen Y; Tan Y; Hu R; Niu MM
Adv Healthc Mater; 2021 May; 10(9):e2002197. PubMed ID: 33690977
[TBL] [Abstract][Full Text] [Related]
7. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-Instructed Self-Assembly (EISA) and Hydrogelation of Peptides.
Gao J; Zhan J; Yang Z
Adv Mater; 2020 Jan; 32(3):e1805798. PubMed ID: 31018025
[TBL] [Abstract][Full Text] [Related]
9. Unraveling the role of Intralipid in suppressing off-target delivery and augmenting the therapeutic effects of anticancer nanomedicines.
Islam R; Gao S; Islam W; Šubr V; Zhou JR; Yokomizo K; Etrych T; Maeda H; Fang J
Acta Biomater; 2021 May; 126():372-383. PubMed ID: 33774199
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Peptide Drug Delivery Systems.
Yang J; An HW; Wang H
ACS Appl Bio Mater; 2021 Jan; 4(1):24-46. PubMed ID: 35014275
[TBL] [Abstract][Full Text] [Related]
11. Preorganization Increases the Self-Assembling Ability and Antitumor Efficacy of Peptide Nanomedicine.
Liang C; Wang Z; Xu T; Chen Y; Zheng D; Zhang L; Zhang W; Yang Z; Shi Y; Gao J
ACS Appl Mater Interfaces; 2020 May; 12(20):22492-22498. PubMed ID: 32352747
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular Nanofibers Formed by Enzyme-Instructed Self-Assembly for SKBR-3 Cell Selective Inhibition.
Wang S; Ma Y; Ma C; Liu K; Huo Z; Shang Y
Chem Asian J; 2022 Jul; 17(14):e202200301. PubMed ID: 35510693
[TBL] [Abstract][Full Text] [Related]
13. Supramolecular "Trojan Horse" for Nuclear Delivery of Dual Anticancer Drugs.
Cai Y; Shen H; Zhan J; Lin M; Dai L; Ren C; Shi Y; Liu J; Gao J; Yang Z
J Am Chem Soc; 2017 Mar; 139(8):2876-2879. PubMed ID: 28191948
[TBL] [Abstract][Full Text] [Related]
14. Supramolecular nanofibers increase the efficacy of 10-hydroxycamptothecin by enhancing nuclear accumulation and depleting cellular ATP.
Guo Q; Liu Y; Wang Z; Zhang J; Mu G; Wang W; Liu J
Acta Biomater; 2021 Mar; 122():343-353. PubMed ID: 33444804
[TBL] [Abstract][Full Text] [Related]
15. Self-Assembled Nanomedicines for Anticancer and Antibacterial Applications.
Zhou L; Qiu T; Lv F; Liu L; Ying J; Wang S
Adv Healthc Mater; 2018 Oct; 7(20):e1800670. PubMed ID: 30080319
[TBL] [Abstract][Full Text] [Related]
16. Pathological environment directed in situ peptidic supramolecular assemblies for nanomedicines.
Chen J; Zhao Y; Yao Q; Gao Y
Biomed Mater; 2021 Feb; 16(2):022011. PubMed ID: 33630754
[TBL] [Abstract][Full Text] [Related]
17. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.
Sun D; Zhou S; Gao W
ACS Nano; 2020 Oct; 14(10):12281-12290. PubMed ID: 33021091
[TBL] [Abstract][Full Text] [Related]
18. A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties.
He W; Yan J; Wang L; Lei B; Hou P; Lu W; Ma PX
Biomaterials; 2019 Jun; 206():13-24. PubMed ID: 30921731
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-instructed self-assembly of a novel histone deacetylase inhibitor with enhanced selectivity and anticancer efficiency.
Gao Y; Zhang C; Chang J; Yang C; Liu J; Fan S; Ren C
Biomater Sci; 2019 Mar; 7(4):1477-1485. PubMed ID: 30672520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
